Skip to content
AwardedSpainGoods

Diagnostikumid Illumina platvormile polügeensete riskiskooride määramiseks ülegenoomse mikrokiibi abil ja analüüsitarkvara

Published
Published 13 February 2026

Overview

Tartu Ülikooli Kliinikum has awarded a four-year framework agreement to Illumina Netherlands BV for 659,211.54 EUR to supply diagnostic reagents for Illumina platforms and analysis software for determining polygenic risk scores using whole-genome microarray. The buyer will order products based on actual healthcare service delivery needs rather than a fixed volume, with the option to increase purchases by up to 30 percent.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
13 February 2026
Classification (CPV)
Diagnostic supplies

Award outcome

Awarded value
€659,212
Award date
2 February 2026
Winner
  • Illumina Netherlands BV

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    13 February 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Diagnostikumid Illumina platvormile polügeensete riskiskooride määramiseks ülegenoomse mikrokiibi abil ja analüüsitarkvara — won by Illumina Netherlands BV — Skim